A Multicenter, Prospective, Randomized, Open-label, Phase 4 Trial Designed to Evaluate the Efficacy of a Telmisartan/S-Amlodipine(TelminuvoTab. 40/2.5mg) on 24-hour BP Control in Hypertensive Patients Inadequately Controlled
Phase of Trial: Phase IV
Latest Information Update: 24 Aug 2017
At a glance
- Drugs Levamlodipine/telmisartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Chong Kun Dang
- 25 Apr 2016 Planned End Date changed from 1 Sep 2017 to 1 Nov 2017.
- 25 Apr 2016 Planned primary completion date changed from 1 Sep 2017 to 1 Nov 2017.
- 04 Apr 2016 Planned End Date changed from 1 Mar 2017 to 1 Sep 2017 as reported by ClinicalTrials.gov